2026 Global: In-Vitro Diagnostics (Ivd) Quality Control Market-Competitive Review (2032) report
Description
The 2026 Global: In-Vitro Diagnostics (Ivd) Quality Control Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Roche Diagnostics, Basel, Switzerland, remains a dominant force in the IVD quality-control market, offering extensive calibrators, controls, and reference materials that support chemistry, immunoassay, and molecular testing across high- and low-volume laboratories. Abbott, Abbott Park, United States, is likewise central to QC through standardized control materials and measurement verification embedded in its broad diagnostic portfolio, enabling reliable performance tracking from clinical chemistry to infectious disease testing. BioMérieux, Marcy-l'Étoile, France, complements this landscape with a comprehensive range of QC products and control panels designed for bacteriology, immunology, and molecular assays, ensuring traceability and inter-lab consistency. By combining robust QC offerings with global service networks, these firms sustain rigorous quality assurance programs, reduce lot-to-lot variability, and support regulatory compliance for routine diagnostics and emerging platforms. They continually invest in reference standards, proficiency testing, and digital QC solutions to harmonize results across vendors and jurisdictions. Quality environments improve patient safety and data integrity.
Thermo Fisher Scientific, Waltham, United States, plays a pivotal role in QC by supplying calibration materials, proficiency testing programs, assay controls, and data-management software that accompany its broad scientific instrumentation and reagents. These QC solutions enable laboratories to verify instrument performance, verify lot-to-lot consistency, and maintain compliance with regulatory guidelines across clinical chemistry, immunoassay, and molecular workflows. Siemens Healthineers, Erlangen, Germany, complements this landscape with QC materials and verification protocols tailored to its diagnostic platforms, enabling standardized performance checks for hematology, chemistry, and imaging workflows. Danaher, Washington, United States, leverages its multi-brand portfolio, including Beckman Coulter Diagnostics, to deliver controls, calibrators, and quality-assurance programs that span immunoassay, chemistry, and transfusion medicine testing, supporting integrated quality management in centralized and point-of-care settings. Across regions, these firms foster harmonization through reference materials, external quality assessment schemes, and digital monitoring platforms that help laboratories meet evolving accreditation standards in diverse clinical settings worldwide.
Ortho Clinical Diagnostics, Raritan, United States, specializes in quality-control materials, assay controls, and proficiency testing programs used across transfusion medicine, clinical chemistry, and infectious disease workflows to ensure assay reliability and inter-laboratory comparability. Sysmex, Kobe, Japan, provides QC products and platform-specific controls for hematology and coagulation testing, along with digital QC analytics that support real-time performance monitoring and trend analysis across high-throughput laboratories. Grifols, Barcelona, Spain, offers QC reagents, calibrators, and material controls tied to its immunoassay and serology portfolios, enabling consistent results in routine screening and complex infection panels while supporting regulatory documentation. Randox, Crumlin, United Kingdom, concentrates on broad QC panels, reference materials, and external quality assessment services that harmonize patient results across diverse test menus and geographies. Collectively, these five groups contribute to a resilient IVD QC ecosystem by providing standardized controls, cross-platform comparability, and continuous quality improvement for laboratories worldwide. Their collaborations drive harmonized reporting globally.
Roche Diagnostics, Basel, Switzerland, remains a dominant force in the IVD quality-control market, offering extensive calibrators, controls, and reference materials that support chemistry, immunoassay, and molecular testing across high- and low-volume laboratories. Abbott, Abbott Park, United States, is likewise central to QC through standardized control materials and measurement verification embedded in its broad diagnostic portfolio, enabling reliable performance tracking from clinical chemistry to infectious disease testing. BioMérieux, Marcy-l'Étoile, France, complements this landscape with a comprehensive range of QC products and control panels designed for bacteriology, immunology, and molecular assays, ensuring traceability and inter-lab consistency. By combining robust QC offerings with global service networks, these firms sustain rigorous quality assurance programs, reduce lot-to-lot variability, and support regulatory compliance for routine diagnostics and emerging platforms. They continually invest in reference standards, proficiency testing, and digital QC solutions to harmonize results across vendors and jurisdictions. Quality environments improve patient safety and data integrity.
Thermo Fisher Scientific, Waltham, United States, plays a pivotal role in QC by supplying calibration materials, proficiency testing programs, assay controls, and data-management software that accompany its broad scientific instrumentation and reagents. These QC solutions enable laboratories to verify instrument performance, verify lot-to-lot consistency, and maintain compliance with regulatory guidelines across clinical chemistry, immunoassay, and molecular workflows. Siemens Healthineers, Erlangen, Germany, complements this landscape with QC materials and verification protocols tailored to its diagnostic platforms, enabling standardized performance checks for hematology, chemistry, and imaging workflows. Danaher, Washington, United States, leverages its multi-brand portfolio, including Beckman Coulter Diagnostics, to deliver controls, calibrators, and quality-assurance programs that span immunoassay, chemistry, and transfusion medicine testing, supporting integrated quality management in centralized and point-of-care settings. Across regions, these firms foster harmonization through reference materials, external quality assessment schemes, and digital monitoring platforms that help laboratories meet evolving accreditation standards in diverse clinical settings worldwide.
Ortho Clinical Diagnostics, Raritan, United States, specializes in quality-control materials, assay controls, and proficiency testing programs used across transfusion medicine, clinical chemistry, and infectious disease workflows to ensure assay reliability and inter-laboratory comparability. Sysmex, Kobe, Japan, provides QC products and platform-specific controls for hematology and coagulation testing, along with digital QC analytics that support real-time performance monitoring and trend analysis across high-throughput laboratories. Grifols, Barcelona, Spain, offers QC reagents, calibrators, and material controls tied to its immunoassay and serology portfolios, enabling consistent results in routine screening and complex infection panels while supporting regulatory documentation. Randox, Crumlin, United Kingdom, concentrates on broad QC panels, reference materials, and external quality assessment services that harmonize patient results across diverse test menus and geographies. Collectively, these five groups contribute to a resilient IVD QC ecosystem by providing standardized controls, cross-platform comparability, and continuous quality improvement for laboratories worldwide. Their collaborations drive harmonized reporting globally.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
